Thor Medical ASA (OSL: TRMED)

Thor Medical ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022
Selling, General & Admin	7.64	3.14	-
Other Operating Expenses	11.89	3.69	-
Operating Expenses	20.26	7.16	-
Operating Income	-20.26	-7.16	-
Interest & Investment Income	2.12	2.02	-
Currency Exchange Gain (Loss)	-0.25	-0.25	-
Other Non Operating Income (Expenses)	-0.07	-0.17	-
Pretax Income	-18.56	-5.56	-
Earnings From Continuing Operations	-18.56	-5.56	-
Earnings From Discontinued Operations	5.5	-21	-311.24
Net Income	-13.06	-26.56	-311.24
Net Income to Common	-13.06	-26.56	-311.24
Shares Outstanding (Basic)	234	175	115
Shares Outstanding (Diluted)	234	175	115
Shares Change (YoY)	-	51.82%	-
EPS (Basic)	-0.06	-0.15	-2.70
EPS (Diluted)	-0.06	-0.15	-2.70
Free Cash Flow	-27.59	-64.09	-414.71
Free Cash Flow Per Share	-0.12	-0.37	-3.60
EBITDA	-	-6.83	-
D&A For EBITDA	-	0.33	-
EBIT	-20.26	-7.16	-

Source: S&P Capital IQ. Standard template. Financial Sources.